$Zai Lab Ltd(ZLAB)$'s outlook

$Zai Lab Ltd(ZLAB)$'s outlook is becoming clearer, and 2025 is undoubtedly its most crucial year since its listing! The stock has adjusted well, and the US rate cuts are a huge boost for financing in the innovative drug sector. The fundamentals are hitting a key turning point. This year, the company is expected to reach break-even, and within three years, revenue could surpass $2 billion.

Winning Trades

Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":408114598342720,"tweetId":"408114598342720","gmtCreate":1740657168415,"gmtModify":1740661846437,"author":{"id":9000000000000421,"idStr":"9000000000000421","authorId":9000000000000421,"authorIdStr":"9000000000000421","name":"PhoenixWhitman","avatar":"https://static.tigerbbs.com/a1ad1b1423595443786a811bd5d0be2b","vip":8,"userType":8,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":11,"starInvestorFlag":false},"themes":[{"themeId":"7516f9ef7e8042739b8597466da26fe7","categoryId":"7cf744760f454845a1870a05ea4e151d","name":"Winning Trades","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":7516f9ef7e8042739b8597466da26fe7}&rnconfig={\"headerBarHidden\": true}","description":"Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.","image":"https://community-static.tradeup.com/news/14c89d9656aedb9a4698e7996c575947"}],"images":[{"img":"https://community-static.tradeup.com/news/f4398239eb6f3c57a812d03db36a87e3","width":"696","height":"1122"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/f4398239eb6f3c57a812d03db36a87e3","width":"696","height":"1122"}],"html":"<html><head></head><body> <a data-mention-id=\"ZLAB\" class=\"teditor-mention\" data-mention-name=\"Zai Lab Ltd\" href=\"https://ttm.financial/S/ZLAB\">$Zai Lab Ltd(ZLAB)$</a>'s outlook is becoming clearer, and 2025 is undoubtedly its most crucial year since its listing! The stock has adjusted well, and the US rate cuts are a huge boost for financing in the innovative drug sector. The fundamentals are hitting a key turning point. This year, the company is expected to reach break-even, and within three years, revenue could surpass $2 billion.<img src=\"https://community-static.tradeup.com/news/f4398239eb6f3c57a812d03db36a87e3\" tg-width=\"696\" tg-height=\"1122\"></body></html>","htmlText":"<html><head></head><body> <a data-mention-id=\"ZLAB\" class=\"teditor-mention\" data-mention-name=\"Zai Lab Ltd\" href=\"https://ttm.financial/S/ZLAB\">$Zai Lab Ltd(ZLAB)$</a>'s outlook is becoming clearer, and 2025 is undoubtedly its most crucial year since its listing! The stock has adjusted well, and the US rate cuts are a huge boost for financing in the innovative drug sector. The fundamentals are hitting a key turning point. This year, the company is expected to reach break-even, and within three years, revenue could surpass $2 billion.<img src=\"https://community-static.tradeup.com/news/f4398239eb6f3c57a812d03db36a87e3\" tg-width=\"696\" tg-height=\"1122\"></body></html>","text":"$Zai Lab Ltd(ZLAB)$'s outlook is becoming clearer, and 2025 is undoubtedly its most crucial year since its listing! The stock has adjusted well, and the US rate cuts are a huge boost for financing in the innovative drug sector. The fundamentals are hitting a key turning point. This year, the company is expected to reach break-even, and within three years, revenue could surpass $2 billion.","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/408114598342720","repostId":0,"isVote":1,"tweetType":1,"viewCount":211,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["ZLAB","09688"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":327,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/408114598342720"}